Company Filing History:
2 out of 1,336 
1 out of 17 
1 out of 2 Years Active: 2023-2025
Title: Innovations by Sang Jun Ha in Pharmaceutical Compositions
Introduction
Sang Jun Ha is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating inflammatory and autoimmune diseases. His work is characterized by a focus on innovative solutions that address complex medical challenges.
Latest Patents
Sang Jun Ha holds 1 patent for his invention titled "Pharmaceutical compositions for preventing or treating inflammatory disease, autoimmune disease, or combination thereof, and method for using same." This patent provides a pharmaceutical composition that includes a compound represented by a specific formula, along with its stereoisomers, derivatives, solvates, or pharmaceutically acceptable salts. The composition is designed to effectively prevent or treat inflammatory diseases, autoimmune diseases, and graft rejection responses.
Career Highlights
Throughout his career, Sang Jun Ha has been associated with prestigious institutions such as Yonsei University and Immunomet Therapeutics Inc. His work in these organizations has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.
Collaborations
Sang Jun Ha has collaborated with notable colleagues, including Jungsik Song and Beom Seok Kim. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the pharmaceutical field.
Conclusion
Sang Jun Ha's contributions to pharmaceutical innovations demonstrate his commitment to addressing critical health issues through research and development. His patent reflects a significant advancement in the treatment of inflammatory and autoimmune diseases, showcasing the importance of innovation in medicine.